James R Klinger MD
Critical Care Medicine, Pleural Disease
Associate Professor, Medicine, Brown University Program in Medicine
Join to View Full Profile
375 Wampanoag TrlSuite 302bRiverside, RI 02915
Phone+1 401-649-4070
Fax+1 401-649-4071
Dr. Klinger is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Rhode Island Hospital/Brown University HealthFellowship, Pulmonary Disease and Critical Care Medicine, 1987 - 1991
Drexel University College of Medicine/Hahnemann University HospitalResidency, Internal Medicine, 1983 - 1987
Medical College of WisconsinClass of 1983
Certifications & Licensure
RI State Medical License 1991 - 2026
PA State Medical License 1984 - 1992
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2011-2013
Clinical Trials
- Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis Start of enrollment: 2009 Nov 01
- Treprostinil Combined With Tadalafil for Pulmonary Hypertension Start of enrollment: 2011 Mar 01
- Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program Start of enrollment: 2011 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 4 citationsTranscriptional profiles of pulmonary artery endothelial cells in pulmonary hypertension.Navneet Singh, Carsten Eickhoff, Augusto Garcia-Agundez, Paul Bertone, Sunita S Paudel
Scientific Reports. 2023-12-18 - 3 citationsEmerging pharmacotherapies for the treatment of pulmonary arterial hypertension.Roger Auth, James R Klinger
Expert Opinion on Investigational Drugs. 2023-11-24 - 2 citationsBurden of pulmonary hypertension due to chronic obstructive pulmonary disease: Analysis of exacerbations and healthcare resource utilization in the United States.James R Klinger, Benjamin Wu, Kellie Morland, Peter Classi, Ryan Fiano
Respiratory Medicine. 2023-09-18
Journal Articles
- Lower DHEA-S Levels Predict Disease and Worse Outcomes in Post-Menopausal Women with Idiopathic, Connective Tissue Disease- and Congenital Heart Disease-Associated Pul...Mary Whittenhall, Andrew E Foderaro, Jason S Fritz, Nicholas S Hill, Ioana R Preston, Pamela Ouyang, Harold I Palevsky, Kari E Roberts, K Akaya Smith, Steven M Kawut, ..., The European Respiratory Journal
Press Mentions
Some Patients with More Severe PH in COPD May Respond to TreatmentAugust 18th, 2021- Some Patients with More Severe PH in COPD May Respond to TreatmentAugust 18th, 2021
New Pulmonary Hypertension Association Accreditation Program and Registry Giving New Understanding to Specialists Caring for People Living with Pulmonary HypertensionFebruary 3rd, 2017- Join now to see all
Grant Support
- SOX17/RUNX1 Axis Regulates Endothelial Cell Fate in the Pathogenesis of Pulmonary Arterial HypertensionRHODE ISLAND HOSPITAL2022–2026
- Natriuretic Peptides In Pulmonary Endothelial Cell Barrier FunctionNational Heart, Lung, And Blood Institute2007–2011
- Mechanisms Of Cardiac Natriuretic Peptide SynthesisNational Heart, Lung, And Blood Institute1994–1998
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
